Neural Regeneration Research ›› 2023, Vol. 18 ›› Issue (12): 2611-2614.doi: 10.4103/1673-5374.373673

Previous Articles     Next Articles

Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease

Júlio César Claudino dos Santos1, 2, *, Leandro Freitas Oliveira3, Felipe Micelli Noleto1, Camilla Teixeira Pinheiro Gusmão4, #br# Gerly Anne de Castro Brito2, 5, #, Glauce Socorro de Barros Viana5, ##br#   

  1. 1Christus University Center - UNICHRISTUS, Fortaleza, CE, Brazil; 2Postgraduate Program in Morphofunctional Sciences, Federal University of Ceará - UFC, Fortaleza, CE, Brazil; 3Universidade Católica de Brasília - UCB, Brasília, DF, Brasil; 4Postgraduate Program in Physiology and Pharmacology Department of the Federal University of Ceará - UFC, Fortaleza, CE, Brazil; 5Physiology and Pharmacology Department of the Federal University of Ceará - UFC, Fortaleza, CE, Brazil 
  • Online:2023-12-15 Published:2023-06-14
  • Contact: Júlio César Claudino dos Santos, PhD, julio.santos@alu.ufc.br.
  • Supported by:
    This work was supported by Medical School of the Christus University Center (UNICHRISTUS), Federal University of Ceará (UFC), and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP; grants 2021/06473-4) (to JCCS).

Abstract: This critical review of the literature shows that there is a close link between the microbiome, the gut, and the brain in Parkinson’s disease. The vagus nerve, the main component of the parasympathetic nervous system, is involved in the regulation of immune response, digestion, heart rate, and control of mood. It can detect microbiota metabolites through its afferents, transferring this gut information to the central nervous system. Preclinical and clinical studies have shown the important role played by the gut microbiome and gut-related factors in disease development and progression, as well as treatment responses. These findings suggest that the gut microbiome may be a valuable target for new therapeutic strategies for Parkinson’s disease. More studies are needed to better understand the underlying biology and how this axis can be modulated for the patient’s benefit.

Key words: alpha-synuclein, enteric microbiota, gastrointestinal tract, Parkinson’s disease, vagus nerve